Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Infections and Infectious Diseases | Pediatrics/Neonatology | Family Medicine
Cytomegalovirus Infections Clinical Trials
A listing of Cytomegalovirus Infections medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : GSK Investigational Site
Study to Explore CMV Infection in Adolescent Girls
California
Los Angeles : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Los Angeles : University of California - Los Angeles
Evaluation of the Artus® CMV PCR Test
San Diego : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
San Francisco : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
San Francisco : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
View More »
Stanford :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Colorado
Denver : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Denver : University of Colorado
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Florida
Miami : University of Miami
Evaluation of the Artus® CMV PCR Test
Tampa : LifeLink Health Care Institute
Evaluation of the Artus® CMV PCR Test
Georgia
Atlanta : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Atlanta :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Atlanta : Emory University Hospital
Evaluation of the Artus® CMV PCR Test
Atlanta : Vanderbilt
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Augusta : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
View More »
Augusta : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Illinois
Chicago : Northwestern University
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Chicago : University of Chicago
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Indiana
Indianapolis : Indiana University
Evaluation of the Artus® CMV PCR Test
Maryland
Baltimore : Johns Hopkins
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Baltimore : SNBL Clinical Pharmacology Center
Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody
Massachusetts
Boston : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Boston : Brigham and Women's Hospital
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Springfield : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Worcester : University of Massachesetts
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Michigan
Ann Arbor :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Detroit : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Stevensville : GSK Investigational Site
Study to Explore CMV Infection in Adolescent Girls
Minnesota
Minneapolis : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Minneapolis : University of Minnesota
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Rochester : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Missouri
St. Louis : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
St. Louis :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
New York
Albany : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Bronx :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Buffalo : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Buffalo : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
New York : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
View More »
New York : Memorial Sloan-Kettering Cancer Center
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Stony Brook : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Ohio
Cincinnati : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Cleveland :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Cleveland : Cleveland Clinic
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Oregon
Portland : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Pennsylvania
Philadelphia : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Philadelphia : University of Pennsylvania
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Pittsburgh : University of Pittsburg Medical Center
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Rhode Island
Providence : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
South Carolina
Charleston :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Charleston : Medical University of South Carolina
Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
Tennessee
Nashville :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Texas
Dallas : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
San Antonio : Updated
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Washington
Seattle : Fred Hutchinson Cancer Research Center
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
Wisconsin
Milwaukee :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Belgium
Brussels : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Bruxelles : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Bruxelles : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Charleroi : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Gent : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
View More »
Ixelles : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
La Louvière : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Leuven : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Leuven : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Mons : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Wilrijk : GSK Investigational Site
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Canada
Edmonton :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Finland
Helsinki : GSK Investigational Site
Study to Explore CMV Infection in Adolescent Girls
Oulu : GSK Investigational Site
Study to Explore CMV Infection in Adolescent Girls
Norway
Oslo : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Spain
Barcelona : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Madrid :
A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Sevilla : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Sweden
Göteborg : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Huddinge : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
Uppsala : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
United Kingdom
Birmingham : QEH Birmingham Hospital
Alternate Donor Study of Pre-Emptive Cellular Therapy
Birmingham : Queen Elizabeth Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Birmingham : Birmingham Heartlands Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Bristol : Bristol Royal Hospital
Alternate Donor Study of Pre-Emptive Cellular Therapy
Bristol : Bristol Royal Hospital for Children
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
View More »
Cambridge : Addenbrookes Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Glasgow : Beatson West of Scotland Cancer Centre
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Leeds : St James's University Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Liverpool : Royal Liverpool Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
London : Updated
A Study of RG7667 for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients
London : Royal Free Hospital
Alternate Donor Study of Pre-Emptive Cellular Therapy
London : Kings College Hospital
Alternate Donor Study of Pre-Emptive Cellular Therapy
London : University College London Hospital
Alternate Donor Study of Pre-Emptive Cellular Therapy
London : Kings College Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
London : Royal Free Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
London : University College Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Manchester : The Christie
Alternate Donor Study of Pre-Emptive Cellular Therapy
Manchester : Manchester Royal Infirmary
Alternate Donor Study of Pre-Emptive Cellular Therapy
Manchester : Manchester Royal Infirmary
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Manchester : Christie Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Nottingham : Nottingham University Hospital - City Campus
Alternate Donor Study of Pre-Emptive Cellular Therapy
Nottingham : City Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Oxford : Churchill Hospital
Alternate Donor Study of Pre-Emptive Cellular Therapy
Southampton : Southampton General Hospital
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
